In a similar retrospective, institutional study of 700 patients undergoing radiation for prostate cancer, a pre-treatment CRP ≥8.6 mg/L was associated with worse cancer-specific survival, overall survival, and clinical disease-free survival. This evidence concerns the gene CRP and Familial prostate cancer.